ALPHAMER TECHNOLOGY
ALPHAMER TECHNOLOGY
Industry:
Biotechnology Health Care Information Technology Pharmaceutical
Founded:
2010-01-01
Status:
Active
Technology used in webpage:
ReCAPTCHA U.S. Server Location Gravity Forms
Similar Organizations
Ability Pharmaceuticals
Ability Pharmaceuticals is a drug discovery and development company.
ARX Technologies
Technology based startup involves research and development of embedded systems
Cal-BRAIN
A Neurotechnology Program for California.
Coelacanth
Coelacanth, which uses proprietary chemistry technologies to rapidly discover new chemical entities for drug development.
Directional Healthcare Advisors, LLC
Healthcare technology management and commercialization
Illumigen Biosciences
Illumigen Biosciences is drug discovery and development firm.
Proteomedix Frontiers
Proteomedix Frontiers is drug discovery and development company.
More informations about "Alphamer technology"
Our Science - Centauri Therapeutics Limited
Our Science Centauri Therapeutics is an immunotherapy company focused on infectious diseases. Centauri’s approach to treating infectious diseases rests upon proprietary Alphamer® technology. All projects harness a powerful and …See details»
Company - Centauri Therapeutics Limited
Our History 2014 The company was established using IP from collaboration with Kary Mullis, PhD and seed investment. 2015 Laboratories at Discovery Park, Kent were established and the name Centauri Therapeutics adopted. Research …See details»
Alphamer Technology gets Seed Fundraising to Fight …
Feb 20, 2017 An alphamer is composed of a DNA aptamer (purple) and an alpha-galactose sugar (blue) The alphamer technology was initially developed by California-based Altermune Technologies, until Centauri acquired it in …See details»
Alphamer technology - Crunchbase Company Profile & Funding
Jan 22, 2016 Alphamer technology for drug discovery and development platform? Acquired by . Centauri Therapeutics Limited . Private; 2,617,878; Highlights. Similar Companies 7. Recent …See details»
Centauri Acquires Alphamer | Technology Networks
Jan 20, 2016 Clive Dix, Chairman of Centauri Therapeutics, said: “The Alphamer platform technology is a unique opportunity to assemble well-characterised building blocks to produce …See details»
BRIEF—Centauri given $1.25m to advance antimicrobials
5 days ago Centauri Therapeutics secured a £1 million ($1.25 million) grant from PACE to advance its Alphamer technology, targeting multidrug-resistant Gram-negative bacteria. The Alphamer platform utilizes a dual mechanism, attacking …See details»
Centauri Therapeutics buys Alphamer immuno-therapeutics …
Jan 18, 2016 Centauri Therapeutics has bought Alphamer technology from Altermune Technologies for an undisclosed amount, for drug discovery and development. The company …See details»
Novo Holdings REPAIR Impact Fund invests in Centauri …
Feb 16, 2022 Centauri is leveraging the Alphamer technology to introduce an innovative drug mechanism that recruits and directs pre-existing antibodies specifically to pathogens, engaging both innate and adaptive immunity to elicit …See details»
UK’s Peakdale signs agreement with Centauri for Alphamer …
Jul 12, 2016 The Alphamer technology is based on programmable immunity, in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens in order to …See details»
Centauri Therapeutics Ltd to Develop Novel Anti-Infective …
Jan 18, 2016 Clive Dix, Chairman of Centauri Therapeutics, said: “The Alphamer platform technology is a unique opportunity to assemble well-characterised building blocks to produce …See details»
Centauri Therapeutics Closes £24 Million GBP Series A Investment …
Feb 16, 2022 Centauri is leveraging the Alphamer technology to introduce an innovative drug mechanism that recruits and directs pre-existing antibodies specifically to pathogens, …See details»
Centauri Therapeutics closes £24 million GBP Series A investment …
Centauri is leveraging the Alphamer technology to introduce an innovative drug mechanism that recruits and directs pre-existing antibodies specifically to pathogens, engaging both innate and …See details»
Centauri Therapeutics Ltd to Develop Novel Anti-Infective …
Feb 11, 2016 Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases, announced today that it has acquired the Alphamer technology for drug …See details»
Centauri Therapeutics Acquires Alphamer Technology from …
Jan 18, 2016 Centauri Therapeutics has acquired the Alphamer immuno-therapeutics platform technology for drug discovery and development from Altermune Technologies. The price was …See details»
Centauri Therapeutics Ltd to Develop Novel Anti-Infective …
Jan 21, 2016 London and Kent, UK, 18 January 2016:Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases, announced today …See details»
Avvinity will have exclusive rights in oncology to use Alphamer ...
Mar 2, 2016 Avvinity will have exclusive rights in oncology to use Alphamer therapeutic platform, invented by a Nobel Laureate and developed by Centauri: A Case of a Joint Venture Model, …See details»
Horizon, Centauri form joint venture to move Alphamer …
Mar 3, 2016 DUBLIN – Avvinity Therapeutics Ltd., a newly created joint venture between Horizon Discovery Group plc and start-up firm Centauri Therapeutics Ltd., is getting up to £5.3 …See details»
Alphamer
Alphamer. Pharmaceutical experts since our inception. Products Trading. Who we are. Alphamer Pharmaceutical is a leading pharmaceutical company due to our strategic positioning and …See details»
Centauri Therapeutics to Develop Novel Anti ... - Technology …
Jan 19, 2016 Company has acquired Alphamer immuno-therapeutics platform technology.See details»